Renaissance Technologies - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 307 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$38,235,112
+88178.3%
2,954,800
-5.2%
0.06%
-4.4%
Q1 2024$43,312
-8.8%
3,118,200
-6.3%
0.07%
-6.8%
Q4 2023$47,482
-5.0%
3,327,400
+3.0%
0.07%
-14.1%
Q3 2023$49,982
-12.8%
3,230,900
-11.5%
0.08%
+2.4%
Q2 2023$57,341
+17.0%
3,650,000
+22.8%
0.08%
+27.7%
Q1 2023$49,002
+9.7%
2,973,400
+3.8%
0.06%
+6.6%
Q4 2022$44,685
-99.9%
2,864,400
+0.5%
0.06%
+17.3%
Q3 2022$36,953,000
-6.9%
2,849,100
+0.7%
0.05%
+10.6%
Q2 2022$39,709,000
+39.1%
2,828,300
+41.9%
0.05%
+42.4%
Q1 2022$28,543,000
+21.8%
1,993,200
+16.0%
0.03%
+13.8%
Q4 2021$23,427,000
-33.7%
1,718,800
-20.3%
0.03%
-37.0%
Q3 2021$35,330,000
-8.6%
2,156,900
-6.1%
0.05%
-4.2%
Q2 2021$38,659,000
-38.4%
2,297,000
-33.1%
0.05%
-38.5%
Q1 2021$62,716,000
-38.2%
3,434,600
-38.4%
0.08%
-29.1%
Q4 2020$101,532,000
-0.8%
5,578,700
-2.8%
0.11%
+7.8%
Q3 2020$102,343,000
+1.8%
5,736,707
+2.3%
0.10%
+17.2%
Q2 2020$100,546,000
+76.0%
5,607,700
+49.0%
0.09%
+58.2%
Q1 2020$57,128,000
+44.2%
3,763,400
+87.4%
0.06%
+83.3%
Q4 2019$39,622,000
+35.2%
2,008,189
+17.8%
0.03%
+20.0%
Q3 2019$29,316,000
+114.0%
1,704,400
+120.3%
0.02%
+108.3%
Q2 2019$13,696,000773,8000.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders